Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 97Terminated 26Recruiting 23Active not recruiting 14Unknown 9Withdrawn 5Not yet recruiting 5Suspended 2No longer available 2Enrolling by invitation 2Available 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Neoplasms 19Prostatic Neoplasms 9Breast Neoplasms 9Melanoma 8Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Pancreatic Neoplasms 6Neoplasm Metastasis 6Ovarian Neoplasms 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Solid Tumors 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Glioblastoma 4Carcinoma, Renal Cell 4Stomach Neoplasms 3Multiple Myeloma 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Mesothelioma 2Lymphoma, T-Cell 2Liver Neoplasms 2

Interventions

Anticoagulants 15'-ACCaagtttcttcAGC-3' 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × INDUSTRY × Adenocarcinoma × Clear all
NCT01337518 2012-12-18

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Enzon Pharmaceuticals, Inc.

Phase 1 Suspended
150 enrolled
Genitourinary

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT00443573 2008-05-07

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

ARCA Biopharma, Inc.

Phase 1/2 Suspended
100 enrolled
Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡